Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
Temozolomide is the current first-line treatment for glioblastoma patients but, because many patients are resistant to it, there is an urgent need to develop antitumor agents to treat temozolomide-resistant glioblastoma. Gossypol, a natural polyphenolic compound, has been studied as a monotherapy or...
Main Authors: | Hee Yeon Kim, Byung Il Lee, Ji Hoon Jeon, Dong Keon Kim, Seok-Gu Kang, Jin-Kyoung Shim, Soo Youl Kim, Sang Won Kang, Hyonchol Jang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/10/595 |
Similar Items
-
Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres
by: Hun Ho Park, et al.
Published: (2021-01-01) -
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
by: Junseong Park, et al.
Published: (2019-01-01) -
Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
by: Hyungsin Kim, et al.
Published: (2019-09-01) -
Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications
by: Liu Y, et al.
Published: (2020-09-01) -
Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)